Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,066

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,786

Class I recallsReasonable probability of serious health consequences

24,313

Class II recallsTemporary or medically reversible health consequences

2,876

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,072 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/whole-foods-market-issues-allergy-alert-undeclared-egg-cabricharme-cheesePublished September 11, 2026

Most affected stateHawaii 200 recalls mention this state

State: ND ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated September 12, 2026 ET

Summary (Year to date)

1,527 recalls have been announced year to date.
Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
The highest complete period was Jun 2026 (297).
Sep 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,313
Class I	9,786
Class III	2,876
Not Yet Classified	2

Download CSV

Recalls by class
Class	Recalls
Class II	24,313
Class I	9,786
Class III	2,876
Not Yet Classified	2

FDA Recall Ongoing Historical recordClass II

Tirzepatide 10 mg/0.5 mL Sterile Solution-2 mL Vial, Rx Only, For Sub-Q Use Only, Compounded Drug Product By: Revive Rx, 3831 Golf Dr A, Houston, TX 77018, NDC: 99000-9278-64.

by Revive Rx LLC dba Revive Rx Pharmacy

Reason: Sub-potent Drug
Published: May 31, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Fentanyl Buccal Tablets CII, 800mcg, packaged in cartons of 28 Buccal Tablets (4 tablets x 7 cards), Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834, NDC 51862-638-28

by Teva Pharmaceuticals USA Inc

Reason: Labeling: Incorrect or Missing Package Insert
Published: May 31, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Fentanyl Buccal Tablets CII, 600mcg, packaged in cartons of 28 Buccal Tablets (4 tablets x 7 cards), Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834, NDC 51862-637-28

by Teva Pharmaceuticals USA Inc

Reason: Labeling: Incorrect or Missing Package Insert
Published: May 31, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Fentanyl Buccal Tablets CII, 400mcg, packaged in cartons of 28 Buccal Tablets (4 tablets x 7 cards), Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834, NDC 51862-636-28

by Teva Pharmaceuticals USA Inc

Reason: Labeling: Incorrect or Missing Package Insert
Published: May 31, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Fentanyl Buccal Tablets CII, 200mcg, packaged in cartons of 28 Buccal Tablets (4 tablets x 7 cards), Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834, NDC 51862-635-28

by Teva Pharmaceuticals USA Inc

Reason: Labeling: Incorrect or Missing Package Insert
Published: May 31, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Fentanyl Buccal Tablets CII, 100mcg, packaged in cartons of 28 Buccal Tablets (4 tablets x 7 cards), Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834, NDC 51862-634-28

by Teva Pharmaceuticals USA Inc

Reason: Labeling: Incorrect or Missing Package Insert
Published: May 31, 2023
Distribution: Nationwide

View recall →

FDA Recall Completed Historical recordClass II

Pain Reliever, Acetaminophen USP Caplets, 500 mg, 225-count bottles packaged in a cardboard carton, Distributed by: Walgreen Co., 200 Wilmot Rd, Deerfield, IL 60015; NDC 0363-9947-35.

by Aurobindo Pharma USA Inc.

Reason: Failed Impurities/Degradation Specifications: firm's investigation due to customer complaints for discoloration found that the product was out of specification for an impurity.
Published: May 31, 2023
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Nafcillin for Injection, USP, 10 gram per Pharmacy Bulk Package, Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195. NDC: 25021-141-99

by Sagent Pharmaceuticals Inc

Reason: Lack of Assurance of Sterility
Published: May 31, 2023
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Nafcillin for Injection, USP, 2 gram per vial, Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195. NDC: 25021-140-10

by Sagent Pharmaceuticals Inc

Reason: Lack of Assurance of Sterility
Published: May 31, 2023
Distribution: Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Nafcillin for Injection, USP, 1 gram per vial, Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195. NDC: 25021-139-10

by Sagent Pharmaceuticals Inc

Reason: Lack of Assurance of Sterility
Published: May 31, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

buPROPrion Hydrochloride Extended-Release Tablets, USP (SR) 150 mg, 60 Tablets, Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ, Manufactured by: Sun Pharmaceutical Industries Limited, Gujrat, India, NDC 47335-737-86

by SUN PHARMACEUTICAL INDUSTRIES INC

Reason: Failed Dissolution Specifications; during stability testing
Published: May 31, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Glimepiride Tablets, USP, 4 mg, RX, Packaged as a) 100-count bottle, NDC# 68001-179-00; b) 500-count bottle, NDC# 68001-179-03, Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213. INDIA. For BluePoint Laboratories

by Amerisource Health Services LLC

Reason: CGMP Deviations: recalling drug products following an FDA inspection.
Published: May 31, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Glimepiride Tablets, USP, 2 mg, RX, Packaged as a ) 100-count bottle, NDC# 68001-178-00; b) 500-count bottle; NDC# 68001-178-03 Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA. For BluePoint Laboratories

by Amerisource Health Services LLC

Reason: CGMP Deviations: recalling drug products following an FDA inspection.
Published: May 31, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Glimepiride Tablets, USP, 1 mg, RX, Packaged as a)100-count bottle, NDC# 68001-177-00; b) 500-count bottle, NDC# 68001-177-03; Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213. INDIA. For BluePoint Laboratories

by Amerisource Health Services LLC

Reason: CGMP Deviations: recalling drug products following an FDA inspection.
Published: May 31, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Methylprednisolone Acetate Injectable Suspension, USP 80 mg/mL, For Intramuscular, Intrasynovial and Soft Tissue Injection Only, Not for Intravenous Use, 1 mL Single Dose Vial, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd. Parenteral Unit, Ahmedabad 382213, India, Amneal Pharamceuticals LLC, Bridgewater, NJ 08807, NDC 70121-1574-01.

by Amneal Pharmaceuticals of New York, LLC

Reason: Labeling: Not Elsewhere Classified; A typographical error was observed in the NDC number on the preprinted Individual Folding Cartons (secondary packaging only). Incorrect NDC Number 70121-1573-1; Correct NDC Number 70121-1574-1.
Published: May 31, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

HyperLyte CR Injection, 250 mL bag, Rx only, Central Admixture Pharmacy Services, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-8094-2, code 7128580942.

by Central Admixture Pharmacy Services, Inc.

Reason: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Published: May 31, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

HyperLyte CR Injection, 500 mL bag, Rx only, Central Admixture Pharmacy Services, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-8094-1, code 7128580941.

by Central Admixture Pharmacy Services, Inc.

Reason: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Published: May 31, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Lidocaine 2% HCl Inj, 500mL bag, Rx only, Central Admixture Pharmacy Services, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-8091-1, code 7128580911.

by Central Admixture Pharmacy Services, Inc.

Reason: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Published: May 31, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Potassium Acetate Injection, 2 mEq/mL, 500 ml bag, Rx only, Central Admixture Pharmacy Services, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-8078-1, code 7128580781.

by Central Admixture Pharmacy Services, Inc.

Reason: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Published: May 31, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Sodium Phosphates Injection 4 mEq/3 mMol/mL, 500 ml bag, Rx only, Central Admixture Pharmacy Services, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-8077-1, code 7128580771.

by Central Admixture Pharmacy Services, Inc.

Reason: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Published: May 31, 2023
Distribution: Nationwide

View recall →

Data last updated: September 12, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.